An overview of the vaccinia virus infectome: A survey of the proteins of the poxvirus-infected cell

Journal of Virology

Volumn 86, Issue 3, 2012, Pages 1487-1499

  Chou, Wayne ^a   Ngo, Tuan ^a   Gershon, D Paul ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEOME; VIRUS PROTEIN;

ARTICLE; CELL FUNCTION; CONTROLLED STUDY; GENE IDENTIFICATION; GENE PRODUCT; GENETIC CODE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; POXVIRUS INFECTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; RNA SYNTHESIS; VACCINIA VIRUS; VIRUS CELL INTERACTION; VIRUS GENE; VIRUS TRANSCRIPTION;

AMINO ACID SEQUENCE; CELL LINE; CHROMATOGRAPHY, LIQUID; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; TANDEM MASS SPECTROMETRY; VACCINIA VIRUS; VIRAL PROTEINS;

POXVIRIDAE; VACCINIA VIRUS;

EID: 84857088612     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.06084-11     Document Type: Article

References (64)

1. Almen MS, Nordstrom KJ, Fredriksson R, Schioth HB. 2009. Mapping the human membrane proteome: a majority of the human membrane proteins can be classified according to function and evolutionary origin. BMC Biol. 7:50.
2. Arakawa Y, Cordeiro JV, Schleich S, Newsome TP, Way M. 2007. The release of vaccinia virus from infected cells requires RhoA-mDia modulation of cortical actin. Cell Host Microbe 1:227-240.
3. Bablanian R, Baxt B, Sonnabend JA, Esteban M. 1978. Studies on the mechanisms of vaccinia virus cytopathic effects. II. Early cell rounding is associated with virus polypeptide synthesis. J. Gen. Virol. 39:403-413.
4. Boersema PJ, Raijmakers R, Lemeer S, Mohammed S, Heck AJ. 2009. Multiplex peptide stable isotope dimethyl labeling for quantitative proteomics. Nat. Protoc. 4:484-494.
5. Boone RF, Moss B. 1978. Sequence complexity and relative abundance of vaccinia virus mRNA's synthesized in vivo and in vitro. J. Virol. 26: 554-569.
6. Braess J, et al. 1999. Leukaemic blasts differ from normal bone marrow mononuclear cells and CD34+ haemopoietic stem cells in their metabolism of cytosine arabinoside. Br. J. Haematol. 105:388-393.
7. Brown JP, Twardzik DR, Marquardt H, Todaro GJ. 1985. Vaccinia virus encodes a polypeptide homologous to epidermal growth factor and transforming growth factor. Nature 313:491-492.
8. Brum LM, Lopez MC, Varela JC, Baker HV, Moyer RW. 2003. Microar-ray analysis of A549 cells infected with rabbitpox virus (RPV): a comparison of wild-type RPV and RPV deleted for the host range gene, SPI-1. Virology 315:322-334.
9. Chung CS, et al. 2006. Vaccinia virus proteome: identification of proteins in vaccinia virus intracellular mature virion particles. J. Virol. 80: 2127-2140.
10. Clamp M, et al. 2007. Distinguishing protein-coding and noncoding genes in the human genome. Proc. Natl. Acad. Sci. U. S. A. 104: 19428-19433.
11. Cooper JA, Moss B. 1979. In vitro translation of immediate early, early, and late classes of RNA from vaccinia virus-infected cells. Virology 96: 368-380.
12. Cordeiro JV, et al. 2009. F11-mediated inhibition of RhoA signalling enhances the spread of vaccinia virus in vitro and in vivo in an intranasal mouse model of infection. PLoS One 4:e8506.
13. Cudmore S, Cossart P, Griffiths G, Way M. 1995. Actin-based motility of vaccinia virus. Nature 378:636-638.
14. Davison AJ, Moss B. 1989. Structure of vaccinia virus early promoters. J. Mol. Biol. 210:749-769.
15. Davison AJ, Moss B. 1989. Structure of vaccinia virus late promoters. J. Mol. Biol. 210:771-784.
16. Dellis S, et al. 2004. Protein interactions among the vaccinia virus late transcription factors. Virology 329:328-336.
17. Dodding MP, Way M. 2009. Nck- and N-WASP-dependent actin-based motility is conserved in divergent vertebrate poxviruses. Cell Host Microbe 6:536 -550.
18. Earl PL, Cooper N, Wyatt LS, Moss B, Carroll MW. 2001. Preparation of cell cultures and vaccinia virus stocks, p 16.16.1-16.16.3. In AusubelFM (ed), Current protocols in molecular biology. Wiley Interscience, New York, NY.
19. Esteban M, Metz DH. 1973. Early virus protein synthesis in vaccinia virus-infected cells. J. Gen. Virol. 19:201-206.
20. Furness G, Youngner JS. 1959. One-step growth curves for vaccinia virus in cultures of monkey kidney cells. Virology 9:386 -395.
21. Guerra S, et al. 2003. Cellular gene expression survey of vaccinia virus infection of human HeLa cells. J. Virol. 77:6493-6506.
22. Hanson CV. 1992. Photochemical inactivation of viruses with psoralens: an overview. Blood Cells 18:7-25.
23. Hiller G, Weber K. 1985. Golgi-derived membranes that contain an acylated viral polypeptide are used for vaccinia virus envelopment. J. Virol. 55:651- 659.
24. Huang CY, et al. 2008. A novel cellular protein, VPEF, facilitates vaccinia virus penetration into HeLa cells through fluid phase endocytosis. J. Virol. 82:7988-7999.
25. Husain M, Moss B. 2003. Evidence against an essential role of COPIImediated cargo transport to the endoplasmic reticulum-Golgi intermediate compartment in the formation of the primary membrane of vaccinia virus. J. Virol. 77:11754 -11766.
26. Ishihama Y, et al. 2005. Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol. Cell Proteomics 4:1265-1272.
27. Ishihama Y, Rappsilber J, Mann M. 2006. Modular stop and go extraction tips with stacked disks for parallel and multidimensional Peptide fractionation in proteomics. J. Proteome Res. 5:988-994.
28. Joklik WK. 1966. The poxviruses. Bacteriol. Rev. 30:33-66.
29. Kas K, Michiels L, Merregaert J. 1992. Genomic structure and expression of the human fau gene: encoding the ribosomal protein S30 fused to a ubiquitin-like protein. Biochem. Biophys. Res. Commun. 187:927-933.
30. Katsafanas GC, Moss B. 2007. Colocalization of transcription and translation within cytoplasmic poxvirus factories coordinates viral expression and subjugates host functions. Cell Host Microbe 2:221-228.
31. Katsafanas GC, Moss B. 2004. Vaccinia virus intermediate stage transcription is complemented by Ras-GTPase-activating protein SH3 domain-binding protein (G3BP) and cytoplasmic activation/proliferation-associated protein (p137) individually or as a heterodimer. J. Biol. Chem. 279:52210 -52217.
32. Kotwal GJ, Moss B. 1988. Analysis of a large cluster of nonessential genes deleted from a vaccinia virus terminal transposition mutant. Virology 167:524-537.
33. Kufe DW, Major PP. 1982. Studies on the mechanism of action of cytosine arabinoside. Med. Pediatr. Oncol. 10(Suppl 1):49-67.
34. Ludwig H, et al. 2005. Role of viral factor E3L in modified vaccinia virusAnkara infection of human HeLa Cells: regulation of the virus life cycle and identification of differentially expressed host genes. J. Virol. 79: 2584-2596.
35. Mense SM, et al. 2006. Gene expression profiling reveals the profound upregulation of hypoxia-responsive genes in primary human astrocytes. Physiol. Genomics 25:435-449.
36. Mercer J, Helenius A. 2008. Vaccinia virus uses macropinocytosis and apoptotic mimicry to enter host cells. Science 320:531-535.
37. Mercer J, Helenius A. 2009. Virus entry by macropinocytosis. Nat. Cell Biol. 11:510 -520.
38. Moss B. 2007. Poxviridae: the viruses and their replication, p 2905-2946. In Knipe DM, et al. (ed), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
39. Moss B, Salzman NP. 1968. Sequential protein synthesis following vaccinia virus infection. J. Virol. 2:1016-1027.
40. Newsome TP, Scaplehorn N, Way M. 2004. SRC mediates a switch from microtubule- to actin-based motility of vaccinia virus. Science 306: 124-129.
41. Niles EG, et al. 1986. Nucleotide sequence and genetic map of the 16-kb vaccinia virus HindIII D fragment. Virology 153:96-112.
42. Pertea M, Salzberg SL. 2010. Between a chicken and a grape: estimating the number of human genes. Genome Biol. 11:206.
43. Pickard MR, Mourtada-Maarabouni M, Williams GT. 2011. Candidate tumour suppressor Fau regulates apoptosis in human cells: An essential role for Bcl-G. Biochim. Biophys. Acta 1812:1146-1153.
44. Postigo A, Cross JR, Downward J, Way M. 2006. Interaction of F1L with the BH3 domain of Bak is responsible for inhibiting vaccinia-induced apoptosis. Cell Death Differ. 13:1651-1662.
45. Postigo A, Martin MC, Dodding MP, Way M. 2009. Vaccinia-induced epidermal growth factor receptor-MEK signalling and the anti-apoptotic protein F1L synergize to suppress cell death during infection. Cell Microbiol. 11:1208-1218.
46. Resch W, Hixson KK, Moore RJ, Lipton MS, Moss B. 2007. Protein composition of the vaccinia virus mature virion. Virology 358:233-247.
47. Risco C, et al. 2002. Endoplasmic reticulum-Golgi intermediate compartment membranes and vimentin filaments participate in vaccinia virus assembly. J. Virol. 76:1839-1855.
48. Rosales R, Sutter G, Moss B. 1994. A cellular factor is required for transcription of vaccinia viral intermediate-stage genes. Proc. Natl. Acad. Sci. U. S. A. 91:3794-3798.
49. Sanz P, Moss B. 1998. A new vaccinia virus intermediate transcription factor. J. Virol. 72:6880-6883.
50. Schmelz M, et al. 1994. Assembly of vaccinia virus: the second wrapping cisterna is derived from the trans Golgi network. J. Virol. 68:130 -147.
51. Schwanhausser B, et al. 2011. Global quantification of mammalian gene expression control. Nature 473:337-342.
52. Sonnberg S, Seet BT, Pawson T, Fleming SB, Mercer AA. 2008. Poxvirus ankyrin repeat proteins are a unique class of F-box proteins that associate with cellular SCF1 ubiquitin ligase complexes. Proc. Natl. Acad. Sci. U. S. A. 105:10955-10960.
53. Sreenivasan Y, Sarkar A, Manna SK. 2003. Mechanism of cytosine arabinoside-mediated apoptosis: role of Rel A (p65) dephosphorylation. Oncogene 22:4356-4369.
54. Tooze J, Hollinshead M, Reis B, Radsak K, Kern H. 1993. Progeny vaccinia and human cytomegalovirus particles utilize early endosomal cisternae for their envelopes. Eur. J. Cell Biol. 60:163-178.
55. Townsley AC, Weisberg AS, Wagenaar TR, Moss B. 2006. Vaccinia virus entry into cells via a low-pH-dependent endosomal pathway. J. Virol. 80:8899-8908.
56. Ward BM, Moss B. 2001. Vaccinia virus intracellular movement is associated with microtubules and independent of actin tails. J. Virol. 75: 11651-11663.
57. Weisswange I, Newsome TP, Schleich S, Way M. 2009. The rate of N-WASP exchange limits the extent of ARP2/3-complex-dependent actin-based motility. Nature 458:87-91.
58. Wiesner J, Vilcinskas A. 2010. Antimicrobial peptides: the ancient arm of the human immune system. Virulence 1:440-464.
59. Wisniewski JR, Zougman A, Nagaraj N, Mann M. 2009. Universal sample preparation method for proteome analysis. Nat. Methods 6:359-362.
60. Wright CF, Oswald BW, Dellis S. 2001. Vaccinia virus late transcription is activated in vitro by cellular heterogeneous nuclear ribonucleoproteins. J. Biol. Chem. 276:40680-40686.
61. Yang Z, Bruno DP, Martens CA, Porcella SF, Moss B. 2011. Genomewide analysis of the 5(′ and 3′ ends of vaccinia virus early mRNAs delineates regulatory sequences of annotated and anomalous transcripts. J. Virol. 85:5897-5909.
62. Yang Z, Bruno DP, Martens CA, Porcella SF, Moss B. 2010. Simultaneous high-resolution analysis of vaccinia virus and host cell transcriptomes by deep RNA sequencing. Proc. Natl. Acad. Sci. U. S. A. 107: 11513-11518.
63. Yang Z, et al. 2011. Expression profiling of the intermediate and late stages of poxvirus replication. J. Virol. 85:9899-9908.
64. Yoder JD, Chen T, Hruby DE. 2004. Sequence-independent acylation of the vaccinia virus A-type inclusion protein. Biochemistry 43:8297-8302.